Navigation Links
Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
Date:7/22/2008

MINNEAPOLIS, July 22 /PRNewswire/ -- Nonin Medical, a leading innovator of physiological monitoring solutions for more than 20 years, has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain -- cerebral oximetry.

Early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favorable results. These data results support the objective to simplify sensor application while improving the usefulness of the measurement.

For over two decades, Nonin Medical has remained at the forefront of noninvasive physiological monitoring with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx(R), the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

"This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical. "We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives."

The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This clearly aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of proprietary interfaces. "We must leave the old business models of protectionism behind," said Tschautscher. "This is one reason why Nonin Medical is actively supporting and driving open communication standards."

About Nonin Medical Inc. - http://www.nonin.com

Minneapolis-based Nonin Medical, Inc. is a medical device company specializing in noninvasive physiological monitoring solutions. Nonin designs, manufactures and services products directly and sells through a distributor network in 125 countries. In addition to selling products under its own brands, OEM and partner relationships extend the Nonin brand advantage to the widest possible audience, benefiting customers who might not otherwise have access to Nonin's healthcare delivery solutions.


'/>"/>
SOURCE Nonin Medical
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
5. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
6. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
7. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
10. Oridion Announces Major Medical Research and Congress Presentations
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
(Date:9/7/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... President and CEO, will be presenting at two investment conferences ... 19 th Annual Global Investment Conference on Tuesday, September ... The conference is being held at the New York Palace ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... Illustrate, Maintain® methodology and industry-leading compliance software, The Guard®, has helped another long-time ... Rights (OCR) HIPAA audit and properly satisfy the law. , Thanks to the ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... and social campaign, “Humans With Vaginas.” The goal is to ignite conversation via ... non-toxic personal care products. The brand has declared September “Humans with Vaginas” month, ...
(Date:9/20/2017)... ... 20, 2017 , ... Medicare doesn’t have the authority to ... for their prescription drugs, according to a new comparison of drug plans by ... behalf, there’s no consistency in drug pricing among drug plans,” states TSCL’s Medicare ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face to Receive ... he emotionally pens his aspirations and goals to better one’s life through God. “The ... Green, while searching in all the wrong places, found a love for writing. Green ...
(Date:9/20/2017)... ... September 20, 2017 , ... Houston, Texas, investment firm CORDA Investment ... 8, and Monday, September 11, off work and rolled up their sleeves to help ... to local homes to start the process of rebuilding. , CORDA founder Bonner C. ...
Breaking Medicine News(10 mins):